Malignant neoplasm of nasopharynx
Chapter 2:Neoplasms
ICD-10 C11 is a billable code used to indicate a diagnosis of malignant neoplasm of nasopharynx.
Malignant neoplasm of the nasopharynx, classified under ICD-10 code C11, refers to cancerous growths that originate in the nasopharynx, the upper part of the throat behind the nose. This type of cancer is often associated with the Epstein-Barr virus (EBV) and is more prevalent in certain geographic regions, particularly Southeast Asia. Symptoms may include nasal obstruction, ear fullness, hearing loss, and neck masses due to lymph node involvement. Diagnosis typically involves imaging studies such as MRI or CT scans, along with biopsy for histological confirmation. Treatment options often include radiation therapy, chemotherapy, or a combination of both, depending on the stage and extent of the disease. The prognosis varies significantly based on the stage at diagnosis and the patient's overall health. Understanding the HPV status is crucial, as certain strains of HPV are linked to oropharyngeal cancers, which can influence treatment decisions and prognostic outcomes.
Detailed treatment plans, staging information, and pathology reports are essential.
Patients presenting with neck masses, nasal obstruction, or ear symptoms.
Ensure accurate coding of treatment modalities and follow-up care.
Radiation treatment plans, dosimetry reports, and follow-up imaging results.
Patients receiving radiation therapy for nasopharyngeal cancer.
Document the specific radiation techniques used and any side effects experienced.
Used for patients receiving radiation therapy for nasopharyngeal cancer.
Radiation treatment plans and patient consent forms.
Oncology specialists should ensure accurate coding of treatment modalities.
HPV status can influence treatment decisions and prognostic outcomes. HPV-positive tumors may respond differently to treatment compared to HPV-negative tumors.
